163 related articles for article (PubMed ID: 31235953)
1. Interferon-λ modulates dendritic cells to facilitate T cell immunity during infection with influenza A virus.
Hemann EA; Green R; Turnbull JB; Langlois RA; Savan R; Gale M
Nat Immunol; 2019 Aug; 20(8):1035-1045. PubMed ID: 31235953
[TBL] [Abstract][Full Text] [Related]
2. Type III interferons, IL-28 and IL-29, are increased in chronic HCV infection and induce myeloid dendritic cell-mediated FoxP3+ regulatory T cells.
Dolganiuc A; Kodys K; Marshall C; Saha B; Zhang S; Bala S; Szabo G
PLoS One; 2012; 7(10):e44915. PubMed ID: 23071503
[TBL] [Abstract][Full Text] [Related]
3. Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier.
Lazear HM; Daniels BP; Pinto AK; Huang AC; Vick SC; Doyle SE; Gale M; Klein RS; Diamond MS
Sci Transl Med; 2015 Apr; 7(284):284ra59. PubMed ID: 25904743
[TBL] [Abstract][Full Text] [Related]
4. Direct IL-6 Signals Maximize Protective Secondary CD4 T Cell Responses against Influenza.
Strutt TM; McKinstry KK; Kuang Y; Finn CM; Hwang JH; Dhume K; Sell S; Swain SL
J Immunol; 2016 Oct; 197(8):3260-3270. PubMed ID: 27647834
[TBL] [Abstract][Full Text] [Related]
5. Prior infection with unrelated neurotropic virus exacerbates influenza disease and impairs lung T cell responses.
Foo IJ; Chua BY; Clemens EB; Chang SY; Jia X; McQuilten HA; Yap AHY; Cabug AF; Ashayeripanah M; McWilliam HEG; Villadangos JA; Evrard M; Mackay LK; Wakim LM; Fazakerley JK; Kedzierska K; Kedzierski L
Nat Commun; 2024 Mar; 15(1):2619. PubMed ID: 38521764
[TBL] [Abstract][Full Text] [Related]
6. Ketogenic diet activates protective γδ T cell responses against influenza virus infection.
Goldberg EL; Molony RD; Kudo E; Sidorov S; Kong Y; Dixit VD; Iwasaki A
Sci Immunol; 2019 Nov; 4(41):. PubMed ID: 31732517
[TBL] [Abstract][Full Text] [Related]
7. Impaired secretion of interferons by dendritic cells from aged subjects to influenza : role of histone modifications.
Prakash S; Agrawal S; Cao JN; Gupta S; Agrawal A
Age (Dordr); 2013 Oct; 35(5):1785-97. PubMed ID: 23007963
[TBL] [Abstract][Full Text] [Related]
8. IFN-λ is protective against lethal oral
Murillo-León M; Bastidas-Quintero AM; Endres NS; Schnepf D; Delgado-Betancourt E; Ohnemus A; Taylor GA; Schwemmle M; Staeheli P; Steinfeldt T
bioRxiv; 2023 Feb; ():. PubMed ID: 36865100
[TBL] [Abstract][Full Text] [Related]
9. Antiviral and Immunomodulatory Effects of Interferon Lambda at the Maternal-Fetal Interface.
Dedloff MR; Lazear HM
Annu Rev Virol; 2024 Jun; ():. PubMed ID: 38848605
[TBL] [Abstract][Full Text] [Related]
10. Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons.
Forero A; Ozarkar S; Li H; Lee CH; Hemann EA; Nadjsombati MS; Hendricks MR; So L; Green R; Roy CN; Sarkar SN; von Moltke J; Anderson SK; Gale M; Savan R
Immunity; 2019 Sep; 51(3):451-464.e6. PubMed ID: 31471108
[TBL] [Abstract][Full Text] [Related]
11. Type I and III interferons disrupt lung epithelial repair during recovery from viral infection.
Major J; Crotta S; Llorian M; McCabe TM; Gad HH; Priestnall SL; Hartmann R; Wack A
Science; 2020 Aug; 369(6504):712-717. PubMed ID: 32527928
[TBL] [Abstract][Full Text] [Related]
12. Type III interferons disrupt the lung epithelial barrier upon viral recognition.
Broggi A; Ghosh S; Sposito B; Spreafico R; Balzarini F; Lo Cascio A; Clementi N; De Santis M; Mancini N; Granucci F; Zanoni I
Science; 2020 Aug; 369(6504):706-712. PubMed ID: 32527925
[TBL] [Abstract][Full Text] [Related]
13. Cell type- and replication stage-specific influenza virus responses in vivo.
Fay EJ; Aron SL; Macchietto MG; Markman MW; Esser-Nobis K; Gale M; Shen S; Langlois RA
PLoS Pathog; 2020 Aug; 16(8):e1008760. PubMed ID: 32790753
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells.
Santer DM; Minty GES; Golec DP; Lu J; May J; Namdar A; Shah J; Elahi S; Proud D; Joyce M; Tyrrell DL; Houghton M
PLoS Pathog; 2020 Apr; 16(4):e1008515. PubMed ID: 32353085
[TBL] [Abstract][Full Text] [Related]
15. Interferon-λ at the Center of the Storm.
Hendricks MR; Savan R
Immunity; 2020 Aug; 53(2):245-247. PubMed ID: 32814024
[TBL] [Abstract][Full Text] [Related]
16. Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupus.
Goel RR; Wang X; O'Neil LJ; Nakabo S; Hasneen K; Gupta S; Wigerblad G; Blanco LP; Kopp JB; Morasso MI; Kotenko SV; Yu ZX; Carmona-Rivera C; Kaplan MJ
Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5409-5419. PubMed ID: 32094169
[TBL] [Abstract][Full Text] [Related]
17. Long-term surviving influenza infected cells evade CD8+ T cell mediated clearance.
Fiege JK; Stone IA; Dumm RE; Waring BM; Fife BT; Agudo J; Brown BD; Heaton NS; Langlois RA
PLoS Pathog; 2019 Sep; 15(9):e1008077. PubMed ID: 31557273
[TBL] [Abstract][Full Text] [Related]
18. Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion.
Broggi A; Granucci F; Zanoni I
J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31821443
[TBL] [Abstract][Full Text] [Related]
19. Interferon lambda in inflammation and autoimmune rheumatic diseases.
Goel RR; Kotenko SV; Kaplan MJ
Nat Rev Rheumatol; 2021 Jun; 17(6):349-362. PubMed ID: 33907323
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
